+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients



Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients



Plos one 12(1): E0170472



Although functional rating scales are being used increasingly as primary outcome measures in spinal muscular atrophy (SMA), sensitive and objective assessment of early-stage disease progression and drug efficacy remains challenging. We have developed a game based on the Microsoft Kinect sensor, specifically designed to measure active upper limb movement. An explorative study was conducted to determine the feasibility of this new tool in 18 ambulant SMA type III patients and 19 age- and gender-matched healthy controls. Upper limb movement was analysed elaborately through derived features such as elbow flexion and extension angles, arm lifting angle, velocity and acceleration. No significant differences were found in the active range of motion between ambulant SMA type III patients and controls. Hand velocity was found to be different but further validation is necessary. This study presents an important step in the process of designing and handling digital biomarkers as complementary outcome measures for clinical trials.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059735617

Download citation: RISBibTeXText

PMID: 28122039

DOI: 10.1371/journal.pone.0170472


Related references

P.6.2 Development of a proof-of-concept device using the Microsoft Kinect to assess movement in infants with spinal muscular atrophy. Neuromuscular Disorders 23(9-10): 770, 2013

Using Data From the Microsoft Kinect 2 to Quantify Upper Limb Behavior: A Feasibility Study. IEEE Journal of Biomedical and Health Informatics 21(5): 1386-1392, 2017

Design and test of a Microsoft Kinect-based system for delivering adaptive visual feedback to stroke patients during training of upper limb movement. Medical and Biological Engineering and Computing 55(11): 1927-1935, 2017

Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscular Disorders 25(3): 212-215, 2015

P.6.1 Clinical and upper limb evaluation at one year of non-ambulant patients with spinal muscular atrophy. Neuromuscular Disorders 23(9-10): 770, 2013

Clinical and genetic analysis of four patients with distal upper limb spinal muscular atrophy. Indian Journal of Medical Research 114(October): 141-147, 2001

Clinical & genetic analysis of four patients with distal upper limb spinal muscular atrophy. Indian Journal of Medical Research 114: 141-147, 2001

Validity and Reliability of Upper Limb Functional Assessment Using the Microsoft Kinect V2 Sensor. Applied Bionics and Biomechanics 2019: 7175240, 2019

Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial. Plos one 10(4): E0121799, 2015

Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy. Revista Chilena de Pediatria 88(1): 92-99, 2017

Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy. Revista Chilena de Pediatria 2016:, 2016

Chronic spinal muscular atrophy simulating facioscapulohumeral type and limb-girdle type of muscular dystrophy. Report of two cases. European Neurology 16(1-6): 90-98, 1977

Chronic Spinal Muscular Atrophy Simulating Facioscapulohumeral Type and Limb-Girdle Type of Muscular Dystrophy. European Neurology 16(1-6): 90-98, 1977

Revised upper limb module for spinal muscular atrophy: 12 month changes. Muscle and Nerve 59(4): 426-430, 2019

Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Human Molecular Genetics 4(9): 1629-1632, 1995